SCHEMBL19036650

SCHEMBL19036650

CNC(=O)c1c(NC)ncn1CC(=O)Nc1ccccc1SCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ YTHDC1 Q96MU7 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HPGD P15428 3/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ MAPT P10636 2/20 0.38
▸ RECQL P46063 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10394340 0.75 GAA (0.54) YTHDC1GAA
SCHEMBL10114441 0.74 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NPSR1KMT2ATP53
SCHEMBL19590970 0.72 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2NPSR1HPGDCYP2C9
SCHEMBL19036473 0.71 YTHDC1 (0.44) YTHDC1ALDH1A1SMN1; SMN2HPGDCYP2C9
SCHEMBL20079687 0.70 KMT2A (0.34) YTHDC1ALDH1A1SMN1; SMN2HPGDCYP2C9
SCHEMBL21133444 0.69 KMT2A (0.34) YTHDC1ALDH1A1SMN1; SMN2HPGDCYP2C9
SCHEMBL11357236 0.68 KMT2A (0.51) ALDH1A1HPGDCYP2C9CYP2C19GAA
SCHEMBL20161578 0.67 HTT (0.50) YTHDC1ALDH1A1SMN1; SMN2CYP2C19GAA
SCHEMBL19036600 0.67 YTHDC1 (0.37) YTHDC1
SCHEMBL20161984 0.66 MEN1 (0.52) ALDH1A1SMN1; SMN2GAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
Send feedback